Anti-cancer drug encapsulated human ferritin nanocage particles permeating tumour vasculature.

In our June 2023 issue

Machine learning in cancer nanomedicine, Ceramic dielectrics and electrolytes for lithium batteries, Grating couplers for photonics, Nanoparticle crystallisation, Carbon nanotubes in inflammation …

Announcements

  • Functional 2D Materials Conference Banner

    Functional 2D materials are being explored for a wide range of applications, including in energy, low-power computing and biosensing. This meeting will cover their applications in electronics, optoelectronics and biosensing, with a special focus on applied research and industrial translation.

  • banner

    In 2020 and 2021, Nature Nanotechnology hosted several panel discussions on exciting topics in nanotechnology. See the recordings here.

Nature Nanotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

  • Graphene, transition-metal dichalcogenides, MXenes and the other members of the flatland family are becoming a rich playground for chemists, enlarging the range of applications these nanomaterials can be used for.

    Editorial
  • Nanotechnology is advancing at an accelerated pace in applications and novel nanomaterials. To become an enabling technology for a more sustainable society, we identify and assess nanomaterials and applications trends with potentially significant environmental implications.

    • Arturo A. Keller
    • Alex Ehrens
    • Bernd Nowack
    Comment
  • The passing of Gordon Moore, an Intel co-founder, is a good time to reflect on the achievements of the semiconductors industry and how nanomaterials could allow Moore’s law to outlive its formulator.

    Editorial
  • Increasing the capacity of biological nitrogen fixation (BNF) is an effective strategy to enhance food security while simultaneously reducing the carbon and nitrogen footprint of agriculture. Nanotechnology offers several pathways to enhance BNF successfully.

    • Mingshu Li
    • Li Gao
    • Peng Zhang
    Comment
  • Nanomedicines are complex drugs where components that have typically been regarded as excipients may now be considered part of the active ingredient. The distinction between the active ingredient and excipients for nanomedicines has important consequences for regulatory review and product development. The dissimilarity in the review of the recent ribonucleic acid (RNA)-based lipid nanoparticles highlights the need for further regulatory alignment on this topic.

    • Eva Hemmrich
    • Scott McNeil
    Comment

Advertisement